?:authorAffiliation
|
-
[\'Strathclyde Institute of Pharmacy & Biomedical Sciences, Glasgow, UK. Electronic address: clivegwilson@mac.com.\', \'University of Manchester, Manchester, UK. Electronic address: Leon.Aarons@manchester.ac.uk.\', \'Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium. Electronic address: patrick.augustijns@kuleuven.be.\', \'Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium.\', \'KTH Royal Institute of Technology, Stockholm, Sweden. Electronic address: darwich@kth.se.\', \'Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium. Electronic address: tom.dewaal@kuleuven.be.\', \'Physiolution Polska, Wrocław, Poland. Electronic address: g.garbacz@physiolution.pl.\', \'Merck Healthcare KGaA, Darmstadt, Germany. Electronic address: simone.hansmann@merckgroup.com.\', \'Physiolution Polska, Wrocław, Poland. Electronic address: dhoc@physiolution.pl.\', \'Sofia University St. Kliment Ohridski, Bulgaria. Electronic address: aivanova@chem.uni-sofia.bg.\', \'NCE Formulation Sciences, Abbvie Deutschland GmbH & Co. KG, Germany. Electronic address: mirko.koziolek@abbvie.com.\', \'National and Kapodistrian University of Athens, Athens, Greece. Electronic address: reppas@pharm.uoa.gr.\', \'Department of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport, University of Greifswald, Germany. Electronic address: jedamzikp@uni-greifswald.de.\', \'National and Kapodistrian University of Athens, Athens, Greece. Electronic address: vertzoni@pharm.uoa.gr.\', \'Division of Pharmacology and Pharmacotherapy, University of Helsinki, Finland. Electronic address: arturo.garcia@helsinki.fi.\']
|